Stock DNA
Pharmaceuticals & Biotechnology
JPY 21,188 Million (Small Cap)
9.00
NA
0.19%
0.37
9.93%
0.82
Revenue and Profits:
Net Sales:
15,768 Million
(Quarterly Results - May 2025)
Net Profit:
780 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.0%
0%
-11.0%
6 Months
-0.65%
0%
-0.65%
1 Year
-4.55%
0%
-4.55%
2 Years
-3.15%
0%
-3.15%
3 Years
7.21%
0%
7.21%
4 Years
-5.53%
0%
-5.53%
5 Years
-11.18%
0%
-11.18%
Astena Holdings Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.85%
EBIT Growth (5y)
12.39%
EBIT to Interest (avg)
21.22
Debt to EBITDA (avg)
1.74
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
1.26
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.25%
ROE (avg)
6.70%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.77
EV to EBIT
8.88
EV to EBITDA
5.14
EV to Capital Employed
0.84
EV to Sales
0.51
PEG Ratio
NA
Dividend Yield
0.21%
ROCE (Latest)
9.45%
ROE (Latest)
8.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - May'25 - QoQ
May'25
Nov'24
Change(%)
Net Sales
15,768.00
15,916.30
-0.93%
Operating Profit (PBDIT) excl Other Income
1,840.00
1,697.30
8.41%
Interest
43.00
23.90
79.92%
Exceptional Items
-150.00
-4,354.20
96.56%
Consolidate Net Profit
780.00
-3,671.00
121.25%
Operating Profit Margin (Excl OI)
75.50%
51.20%
2.43%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Consolidated) - Nov'24
Nov'24
Nov'23
Change(%)
Net Sales
57,993.40
51,984.40
11.56%
Operating Profit (PBDIT) excl Other Income
5,402.90
3,666.10
47.37%
Interest
88.60
73.90
19.89%
Exceptional Items
-4,525.70
-532.60
-749.74%
Consolidate Net Profit
-2,538.00
1,153.30
-320.06%
Operating Profit Margin (Excl OI)
48.60%
21.70%
2.69%
USD in Million.
Net Sales
YoY Growth in year ended Nov 2024 is 11.56% vs 4.73% in Nov 2023
Consolidated Net Profit
YoY Growth in year ended Nov 2024 is -320.06% vs 100.82% in Nov 2023
About Astena Holdings Co., Ltd. 
Astena Holdings Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






